retatrutide phase 2 trial results obesity Retatrutide in Canada: Clinical Results, Cost Expectations, and Patient Experience retatrutide clinical trials phase approval:

PubMed pubmed.ncbi.nlm.nih.gov [54] Semaglutide for the treatment of obesity PubMed pubmed.ncbi.nlm.nih.gov [55] Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data ScienceDirect science/article/abs/pii/S0168822723001006

Patients were allowed to increase the insulin dose only up to the starting insulin dose prior to randomization

A structured literature search was conducted using PubMed and Scopus databases up to January 2026

1: ONLSO Ergothioneine Whitening & Cell Activation Tablets No